期刊文献+

冠状动脉雷帕霉素洗脱支架置入术对患者血清CRP及IL-2水平的影响及临床价值 被引量:8

下载PDF
导出
摘要 目的评价冠状动脉雷帕霉素洗脱支架置入术对患者C反应蛋白(CRP)及白细胞介素2(IL-2)的影响及临床应用价值。方法入选51例Braunwald分级ⅡB级的不稳定心绞痛患者,进行择期冠状动脉腔内雷帕霉素洗脱支架置入术。于术前、术后2h、术后14h留取血清样本应用免疫透射比浊法测定CRP水平,保存血清样本于-20℃冰箱一个月,应用酶联免疫分析法测定IL-2水平。结果45例患者成功置入雷帕霉素洗脱支架,术前、术后2h、术后14h血清CRP水平分别为9.5±3.8、11.8±5.6、22.8±11.2mg/dl(P<0.05),血清IL-2水平分别为50.8±23.5、42.1±15.3、6.3±3.5ng/ml(P<0.05)。进一步进行亚组分析,19例置入Cypher支架与23例置入Firebird支架的患者CRP与IL-2水平无统计学上的差异。结论雷帕霉素洗脱支架置入术后CPR水平逐渐升高,IL-2水平逐渐降低;CRP与IL-2均可作为冠状动脉支架置入术后炎症反应强弱的指标,两者具有一定的相关性。本组患者Cypher支架与Firebird支架对CRP与IL-2的影响无统计学上的差异。
出处 《心脑血管病防治》 2008年第1期31-32,共2页 CARDIO-CEREBROVASCULAR DISEASE PREVENTION AND TREATMENT
  • 相关文献

参考文献9

  • 1HehrleinC, WeinschenkI, MetzJ. Long period of balloon inflammation and the implantation of stents potentiate smooth musclecell death. Possible role of chronic vascular injury in restenosis [ J ]. Int J Cardio vasc intervent, 1999, 2(1):21-26.
  • 2Farb A, Weber DK, Kolodgie FD, et al. Morphological predictors of restenosis after coronary stenting in humans [ J ]. Circulation, 2002, 105 (9) :2974 - 2980.
  • 3Gaspardone A, Grea F, Versaci F, et al. Gioffre PA. Predictive value of C-reactive protein after successful coronary-artery stenting in patients with stable angina[J]. Am J Cardiol, 1998, 82(3) :515 - 518.
  • 4Grander W, Dichtl W, Prokop W, et al. C-reactive protein plasma levels but not factor Ⅶ activity predict clinical outcome in patients undergoing elective coronary intervention[J]. Pachinger O Clin Cardiol, 2004, 27 (4) :211 - 216.
  • 5Hoshida S, Nishino M, Takeda T, et al. A persistent increase in C-reactive protein is a risk factor for restenosis in patients with stable angina who are not receiving statins[J]. Atherosclerosis, 2004, 173(2):285- 290.
  • 6Weis M, Hartmann A, Scheuermann EH, et al. Soluble IL-2 receptor levels as a marker of coronary microvascular dysfunction after heart transplantation[J]. J Heart Lung Transplant, 1998, 17(7) :294 - 298.
  • 7Takeshita S, Isshiki T, Ochiai M, et al. Systemic inflammatory responses in acute coronary syndrome: increased activity observed in polymorphonuclear leukocytes but not T lymphocytes[J]. Atherosclerosis, 1997, 135 (4) : 187 - 192.
  • 8王健,颜红兵,朱小玲,高海,李南,艾辉.非选择性冠心病患者应用国产西罗莫司药物洗脱支架6个月随访研究[J].中国医师杂志,2007,9(7):873-874. 被引量:1
  • 9陈方,高阅春,何继强,李峥,吴常燕,张晓玲,李宇,赵华,汪烨,韩智红,张维东.国产与进口雷帕霉素药物洗脱支架治疗冠心病的疗效比较[J].中华心血管病杂志,2006,34(11):994-996. 被引量:13

二级参考文献10

  • 1李光,周颖玲,陈纪言.雷帕霉素洗脱支架在冠心病患者中应用一年后的疗效[J].介入放射学杂志,2005,14(1):15-17. 被引量:10
  • 2调查协作组,霍勇.中国多中心药物洗脱支架急性或亚急性血栓的调查[J].中国介入心脏病学杂志,2005,13(3):131-134. 被引量:24
  • 3Moses JW, Leon NB, Pomma JJ, et al. Sirolimus-eluting stents versus standard stent in patients with stenosis in a native coronary artery. N Engl J Med ,2003,349 : 1315-1323.
  • 4Mckeage K, Mudoch D, Goa KL. The sirolimus-eluting stent: a review if its use in treatment of coronary artery disease. Am J Cardiovasc Drugs ,2003, 3:211-230.
  • 5Morice MC,Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus -eluting stents with a standard stent for coronary revascularization. N Engl J Med,2002,346 : 1773-1780.
  • 6Sousa JE, Serruys PW, Costa MA. New frontier in cardiology:drug- eluting stents, part Ⅰ Circulation ,2003,107:2274-2279.
  • 7Sousa JE, Serruys PW, Costa MA. New frontier in cardiology:drug- eluting stents, part Ⅱ Circulation ,2003,107:2383-2389.
  • 8Pedro A, Lee CH, Francesco S, et al. Early outcome after sirolimus-eluting stent implantation in patients with acute coronary syndromes. Am Coil Cardiol, 2003,41 : 2093 -2099.
  • 9徐波,高润霖.China cypher select registry研究最终结果公布[2006-6-22]http://www.365heart.con/tabloid/2006/06/temp-12873.html.
  • 10Sino-SIRIUS研究组.国人应用雷帕霉素药物洗脱支架预防再狭窄的初步经验——Sino-SIRIUS临床试验[J].中华心血管病杂志,2003,31(11):814-817. 被引量:32

共引文献12

同被引文献137

引证文献8

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部